Cell transplantation therapy has long been investigated as a therapeutic intervention for neurodegenerative disorders, including spinal cord injury, Parkinson's disease, and amyotrophic lateral sclerosis. Indeed, patients have high hopes for a cell-based therapy. However, there are numerous practical challenges for clinical translation. One major problem is that only very low numbers of donor cells survive and achieve functional integration into the host. Glial scar tissue in chronic neurodegenerative disorders strongly inhibits regeneration, and this inhibition must be overcome to accomplish successful cell transplantation. Intraneural cell transplantation is considered to be the best way to deliver cells to the host. We questioned this view with experiments in vivo on a rat glial scar model of the auditory system. Our results show that intraneural transplantation to the auditory nerve, preceded by chondroitinase ABC (ChABC)-treatment, is ineffective. There is no functional recovery, and almost all transplanted cells die within a few weeks. However, when donor cells are placed on the surface of a ChABC-treated gliotic auditory nerve, they autonomously migrate into it and recapitulate glia-and neuron-guided cell migration modes to repair the auditory pathway and recover auditory function. Surface transplantation may thus pave the way for improved functional integration of donor cells into host tissue, providing a less invasive approach to rescue clinically important neural tracts.
astrocyte | auditory system | cell transplantation | glial scar | neurodegenerative diseases C ells transplanted into the nervous system could cure various forms of neurodegenerative disease and neural injury (1, 2), but most donor cells die without functional integration (3) , and glial scar tissue is strongly inhibitory to axon regeneration (4) . Glial scar tissue forms following conditions such as ischemia or mechanical trauma when reactive astrocytes increase proliferation, become hypertrophic, and up-regulate glial fibrillary acidic protein (GFAP) (5, 6) . In this study, however, we demonstrate that if donor cells are delivered appropriately, they can interact successfully with the glial scar and restore lost neuronal function. We developed an in vivo model of the chronic gliotic environment in clinical patients by compressing the rat auditory nerve without breaching the fluid spaces that contain the sensory structures inside the cochlea (7) (8) (9) (10) . In this model, spiral ganglion cells (the auditory neurons) degenerate selectively, but hair cells are preserved both morphologically and functionally (7, 8, 10, 11) . We then waited 5 wk before cell transplantation to allow the formation of a glial scar with the progressive degeneration of auditory neurons. We characterized the glial scar with several experimental measures. This characterization is an important element because experimental models for cell-based therapies for neurodegenerative diseases should include the chronic gliotic environment to simulate the appropriate clinical condition in patients.
To compress the auditory nerve, the CNS portion was atraumatically exposed in the cerebellopontine angle cistern through right suboccipital craniectomy, a nerve hook was placed into the internal auditory meatus, and the nerve was injured by a single compression ( Fig. 1 A and B and Fig. S1A ). We used a murine auditory neuroblast cell line for transplantation (US/VOT-N33) (12) . This cell line was derived from the ventral otocyst (inner ear anlage) of a mouse embryo at embryonic day ED10.5 and was selected because it expresses key markers for auditory sensory neurons and differentiates with the appropriate bipolar morphology in the ear both in vitro and in vivo (11, 12) .
In the first experiments, we delivered cells into the auditory nerve via a thin fused silica tube (Fig. S1B) , treating the nerve topically with chondroitinase ABC (ChABC) (13) soaked in a gelatin sponge at the time of nerve injury and then again immediately after cell transplantation. Three months later, we assessed the structural and functional recovery of the auditory nerve.
During these experiments, we noticed that donor cells that spilled onto the surface of the nerve were apparently able to enter the ChABC-treated tissue and to survive. Thus, we reasoned that cell delivery onto the surface of the glial scar might be successful and less invasive. In this context, we designed an experiment to
Significance
Cell transplantation can restore function in neurodegenerative disorders, but the low rate of functional integration of donor cells into host is a major limiting factor for clinical application. This problem is closely related to the long-standing view that donor cells must be transplanted intraneurally. We show that glial scar, which is common in neurodegenerative conditions, inhibits the survival of intraneurally transplanted cells in our rat glial scar model in the auditory system. However, cells placed on the surface of scar tissue autonomously enter the nerve and become functionally integrated into the host. The glial scar, normally considered to be a barrier to cell transplantation, includes important structural and chemical cues that are disrupted by intraneural delivery but preserved by surface transplantation.
compare two methods of cell delivery. In the first, we applied the conventional method of intraneural infusion, and in the second, we delivered cells to the surface of the nerve without mechanical damage to its structure. We then compared the results in terms of cell morphology and functional recovery of the auditory system.
Results
An Auditory System Model of the Glial Scar. The CNS portion of normal auditory nerve is relatively long compared with other cranial nerves, and it projects into the auditory nerve trunk (14) . The transitional zone between the PNS (peripheral nervous system) and the CNS lies within the temporal bone, distal to the internal auditory meatus (Fig. 1A) (15) . It is defined by the boundary of the expression of GFAP, which is expressed only by the astrocytes in the CNS ( Fig. 1 A and B, Left) . Following compression, numerous changes occur that are characteristic of glial scar formation and that we confirmed in our model.
We first characterized the glial scar with antibodies to GFAP (6) , which showed that compression in one ear led to thinning of the auditory nerve and extension of the GFAP domain peripherally (Fig. 1B) . Glial scar processes were observed to pass through Rosenthal's canal toward the habenula perforata through which the distal auditory neurons reach the hair cell regions (Fig.  1C) . Immunofluorescence for GFAP was increased relative to the sham ear (Fig. 1D) . The levels of GFAP protein in the compressed tissue were higher than in the sham-operated ear (Fig. 1E) , and the corresponding levels of mRNA expression were significantly higher after 1, 4, and 25 wk (Fig. 1F ). Immunofluorescence and mRNA for neurocan, a class of chondroitin sulfate proteoglycans (CSPGs) that are predominantly produced by reactive astrocytes and that inhibit regeneration in the CNS (16), increased significantly ( Fig. 1  G and H) . Finally, mRNA for nestin, which is another hallmark of reactive gliosis (5, 6) , increased significantly 4 wk after compression (Fig. 1I) , and nestin-positive glial scar processes were observed mainly at the compression site (Fig. 1J) . Treatment of compression-induced glial scars with ChABC was evaluated using the monoclonal antibody 2B6, which provides a measure of CSPG digestion (13) . Five weeks after compression with ChABC treatment, the antibody strongly labeled the scar, demonstrating effective digestion of CSPGs (Fig. 1K ).
Functional Recovery Following Cell Transplantation. In our animal surgery, the lateral part of the cerebellum was removed to fully expose the auditory nerve, inevitably resulting in a substantial change of bioelectric volume conductor around the auditory nervous system. Therefore, there was little value in comparing the auditory-evoked brainstem response (ABR) before surgery with that after a large volume of the cerebellum was removed. Hence, we compared ABRs immediately before cell transplantation (5 wk after auditory nerve compression) and 3 mo after cell transplantation, as there was no substantial volume change around auditory nervous system in these two stages.
There was no improvement in the ABRs after 3 mo in any of the 20 animals in which cells were delivered by intraneural transplantation to ChABC-treated gliotic auditory nerves ( (18) (Fig. S2 A and B) , but they were attenuated by the direct mechanical injury and glial scar formation (Fig. S2C) . Thus, we evaluated function by measuring wave III, which originates in the contralateral superior olivary complex (SOC), more central than the origins of wave I and II (Fig. S2A ). Its amplitude reflects activity entering the SOC via the cochlear nucleus and auditory nerve. There were significant improvements in wave III amplitude and threshold ( Fig. 2 D-H and Table S1 ). Latency analysis revealed that conduction velocity recovered in the 16-kHz region but not in the 4-and 8-kHz regions ( Fig. 2I and Table S1 ). This difference may be because the 16-kHz region was nearest to the transplantation site, allowing more time for myelination, so a similar recovery might have occurred at 4 and 8 kHz over a longer period. In the sham rats to which the medium-soaked gelatin sponge and fibrin glue were placed on the nerve (n = 5), no significant changes in the ABRs were observed 3 mo later, indicating that spontaneous recovery did not occur 5 wk after auditory nerve compression.
Integration of Donor Cells to the Auditory Nerve. We observed no evidence of significant cell survival or integration after 3 mo in any of the 20 animals in which cells were delivered by intraneural transplantation to ChABC-treated gliotic auditory nerves. Furthermore, there was clear evidence of cell debris from the donor cells within the nerve ( Fig. 3 A and B) . In stark contrast, cells transplanted on the surface of the glial scar did not die but survived attached to the surface of the auditory nerve and the brainstem ( Fig. 3 C and D) . There was evidence that groups of at least 15-20 cells had entered the auditory nerve 3 mo after cell transplantation (Fig. 3E) . In some cases, the cells appeared to migrate into the nerve in a chain formation (Fig. 3 F and G) or aligned within conduit-like structures in the glial scar ( Fig. 3 H  and I ). Transplanted cells that entered the proximal portion of the glial scar appeared to be guided by hypertrophic astrocytic processes and migrated distally within the scar (Fig. 3 J-M) .
Inside the nerve, transplanted cells were closely associated with GFAP+ processes (Fig. 4 A and B) , reminiscent of gliaguided migration of newborn neurons in the developing cortex (19, 20) . Astrocytes at the lesion appeared to lose their stellate morphology and to adopt overlapping, elongated morphologies (21) (Fig. 4C) . Among them, the transplanted cells were often organized in chains within the elongated GFAP+ processes (Fig.  4 D and E) . This behavior resembles the rostral migratory stream (RMS) where neuroblasts migrate within a tube-like structure, ensheathed by specialized GFAP+ astrocytes (22, 23) .
Neurons can use existing axons for guidance (24) , which seemed to be reiterated in our study (Fig. 4F) . We found numerous donor cells attached to residual neurons (Fig. 4 G and H) and with lengthy GFP (green fluorescent protein)+ projections (Fig. 4I) . Residual neurons seemed to provide a scaffold in the core of dense anisomorphic glial scar tissue where thick GFAP+ glial scar processes lost their longitudinal orientation (Fig. 4 J-M) .
Synaptic Connections at the Proximal and Distal Ends of the Auditory
Nerve. The ABR results imply that cells transplanted to the nerve surface form synapses both with hair cells and with neurons in the cochlear nuclei in the hindbrain. Evidence for such connections has been shown previously in a subacute model of cell therapy in the auditory system (25) . We observed bundles of neurites expressing eGFP in Rosenthal's canal to the habenula perforata (HP, foramina nervosa; Fig. 5 ). More specifically, at the basal and perinuclear regions of inner hair cells, we found eGFP labeling colocalized with punctate labeling for the glutamate receptor subunits GluR2/3 (α-amino-3-hydroxy-5-methyl- 4-isoxazolepropionic acid receptor, AMPAR 2/3) (26) (Fig. 6A) . This immunohistochemical finding provides strong evidence for innervation of hair cells by projections from the donor cells, particularly because postsynaptic glutamate receptors do not survive loss of auditory afferent neurons without cell transplantation (27) .
In our experimental model, the posteroventral cochlear nucleus (PVCN) is affected most, the dorsal cochlear nucleus (DCN) less, and the anteroventral cochlear nucleus (AVCN) was not affected (8) . Hence, to most clearly evaluate how the transplanted cells reinnervate cochlear nucleus cells, we chose to evaluate the PVCN. We observed a GFP+ process projecting toward the CN (Fig. 6B) , and in animals with improved ABRs, eGFP and synaptophysin were colocalized in significantly larger numbers of ovoid cells, which were probably globular bushy cells, than in those without ABR improvements (Fig. 6 C and D) . The survival of CN cells depends on input from auditory neurons, so the cochlear nucleus cells that received neurites from transplanted cells had probably survived as a result (28) .
Correlation Between Cell Survival and Functional Recovery. We saw no functional recovery or cell survival with intraneural transplantation. With surface transplantation, we observed recovery of the ABRs in 10 of 17 animals treated. In those 10 animals, the number of detectable donor cells after 3 mo was significantly higher than in the remaining 7 ( Fig. 7 A-D) , but the residual numbers of endogenous spiral ganglion cells was similar ( Fig. 7 E and F) . This result provides strong evidence that the transplanted cells contributed to the observed improvements of wave III amplitudes, thresholds, and conduction velocity. It also reveals a striking difference between the two methods of cell delivery, with greater functional recovery being linked to the less invasive method of surface transplantation.
Cues for Inward Migration of Surface Cells. The cues that guide the migration of transplanted cells are unknown. However, in our model, the hair cells remain intact (10), and they should provide a source of neurotrophins, notably BDNF (brain-derived neurotrophic factor) and neurotrophin 3, which are indispensable for the maintenance and survival of auditory neurons (28) . Correspondingly, auditory neurons express the relevant receptors, trkB and trkC, respectively (28) . We found that BDNF concentrations were higher in ChABC-treated tissue (Fig. 8A) and that the transplanted cells expressed TrkB receptors (Fig. 8 B-E) .
Discussion
We show that in our auditory nerve model, cells delivered to the surface of ChABC-treated glial scars can migrate into the nerve, extend neuritic processes, and form synaptic connections to their peripheral and central targets. This morphological result is associated with significant functional recovery of the auditory pathway. In contrast, cells delivered by intraneural infusion die without either integration or functional recovery. Most experiments in cell transplantation and axon regeneration have been performed soon after injury and before the glial scar has developed (13, 29, 30) . Our transplantation model is designed to reflect the clinical situation in terms of damage, glial scar formation, and subsequent surgery. In this model, changing the degree of compression provides a wide range of reproducible nerve injury as observed in human neurodegenerative diseases.
Our results suggest that the glial scar contains critical structural and chemical cues that should be preserved during transplantation. Intraneural delivery either destroys those cues or places the cells immediately into a hostile cellular environment that does not allow them to engage with the tissue. In human neurodegenerative diseases, pathological processes progress chronically but numerous axons remain functional even at advanced stages (31) . Infusion pressure and the infused cell mass during surgery may damage these residual neurons. Moreover, intraneural damage may reactivate the process of glial scar formation again as observed in surgical removal of glial scar tissue (32) . In contrast, surface delivery may enable cells to make appropriate adaptations to the tissue matrix to ensure that they survive once they migrate into the nerve. We show that BDNF could be an important guidance and survival factor in our model. The relatively higher survival rate (13.7%) of the transplanted cells in this experiment may have been due to the delivery site, where there were appropriate cues from the sensory epithelium and nutrients from the cerebrospinal fluid. The removal of CSPG side chains by ChABC might facilitate the diffusion of BDNF through the nerve from the hair cells (33) , and the gradient might be preserved better without damage by intraneural intervention. Nevertheless, there are many other soluble signaling molecules that could be important. Furthermore, there are numerous intercellular interactions, mediated by molecules such as N-cadherin and neural cell adhesion molecule, which play a crucial role in regenerating and directing axons (34) . In a study where dorsal root ganglion neurons were seeded onto organotypic slices containing the corpus callosum, the donor neurons regenerated lengthy axons along the processes of gliotic astrocytes, and fibronectin expressed on the surface of the astrocytes was an important factor for this regeneration (35) . Intriguingly, donor cells appeared able to jump from one astrocytic process to another (35) . Such cues are likely to be important for integration of transplanted cells in our model.
The structure of the scar is likely to be critical for the integration of transplanted cells. In our study, glial processes projected distally into the small bony canals beyond the fundus of the internal auditory canal, and this phenomenon was observed equally in animals with and without ChABC treatment (Figs. 1 B , Right, and C and 3A), indicating ChABC did not change the basic framework of the glial scar as far as we can judge from the GFAP immunohistochemistry. However, ChABC apparently aided the donor cells to efficiently exploit preserved positive cues because it digests glycosaminoglycan (GAG) chains of CSPGs and removes their inhibitory influence (36) . GAG chains of CSPGs interact with inhibitory neuronal receptors, including receptor protein tyrosine phosphatase sigma (RPTPσ), leukocyte common antigen-related (LAR) phosphatase, and Nogo receptors 1 and 3 (NgR1 and 3), preventing axon regeneration (29, 30, 36) . In addition to such receptor-mediated mechanisms, it was recently demonstrated that ChABC modifies the immunoinflammatory process of the injured CNS (37, 38) . Macrophages have two distinct polarized phenotypes, M1 and M2, depending on the local tissue environment (39) . In the acute stage of spinal cord injury, proinflammatory M1 macrophages dominate the lesion, but during the resolution stage, they are replaced by anti-inflammatory M2 macrophages (40) . M2 macrophages produce anti-inflammatory cytokines including IL-10 (40) , and several in vivo experimental studies indicate IL-10 promotes recovery after spinal cord injury (41, 42) . Recently, it was demonstrated that viral overexpression of ChABC induced antiinflammatory M2 macrophage polarization (37) accompanied with increased expression of IL-10, resulting in reduced tissue loss in rat spinal cord injury (38) .
Following spinal cord injury in amphibians and fish, glial (astrocytic) bridges span the injury site and guide neuritic growth, resulting in remarkable functional recovery (43) . Experimentally, many cells, matrices, and nerve grafts have been investigated as the bridge to fill the lesion in mammals (44) . In this context, it is reported that immature astrocytes injected along with ChABC are capable of forming the bridge-building process beyond the gliotic lesion in the adult rat cingulum, probably through a matrix metalloproteinase-2 (MMP-2)-dependent mechanism (44). In our study, a "glial scar bridge" was effectively formed from endogenous astrocytes (Fig.  1 B, Right, and C) , which may have helped to guide donor cells and to support neurite elongation. In cell transplantation, the transition zone between the CNS and PNS (Fig. 1A) can be a significant barrier for cell migration and neurite extension (45) . However, this may be overcome by the formation of glial scar bridge.
Neuron-guided cell migration may also be important. We observed residual neuronal elements in glial scar tissue that lacked parallel alignment of glial processes, and these residual neurons were used by the donor cells as the scaffold (Fig. 4 J-M) . Hence, delayed clearance of myelin debris, uniquely observed in CNS degeneration and regarded as an inhibitory factor for axon regeneration (46) , is not necessarily disadvantageous for donor cells in cell transplantation therapy (35, 44) . Taken together, transplanted cells seem to use complementary structural and chemical Approximately 83-87% of SGCs degenerated after auditory nerve injury. The data are from four sham-operated rats, six rats with ABR improvement, and four rats without ABR improvement. AuN, auditory nerve. (Scale bars, 500 μm in left panels of A-C; 50 μm in right panels of C and E; and 40 μm in right panels of A and B.) *P < 0.05, ***P < 0.01, ****P < 0.001. guidance cues from both neurons and glial cells, depending on the environment surrounding them (Fig. 4) .
Survival, differentiation, and integration of donor cells depend on their molecular programs and their ability to respond to the host environment (47) . Our donor cells were region-restricted precursor cells at a relatively late stage of inner ear development (12) . Precursor cells have numerous advantages over less committed, proliferating progenitors because precursors with defined transcription factors expressed at a specific ontogenetic stage have more chance to be integrated into the host than progenitor or stem cells that have not yet begun to express such factors (48) .
Cell therapy for neuronal regeneration is an ambitious goal in restorative medicine, and numerous practical steps must be addressed for effective clinical translation. In our experiments, the average improvement of ABR thresholds was about 10 dB SPL (Fig.  2 E, F, and H) , which is clinically relevant because serviceable function can be achieved with a relatively small number of functional neurons. With only 5-10% of the total axonal population, patients with a cochlear implant are able to hear (49) . Coincidentally, a similar value of functional motor neurons can enable patients to become mobile (50) . Thus, we believe that surface transplantation is a less invasive technique that could have more widespread application to the nervous system. In amyotrophic lateral sclerosis (ALS), anterior horn cells and axons often degenerate (51) . Suitable donor cells applied on the surface of degenerated anterior roots of the spinal cord could provide a minimally invasive method of cell transplantation to restore lost function of the motor neurons. Similarly, surface transplantation of appropriate motor neuron precursors may ameliorate neurological deficit due to poliomyelitis in which anterior horn cells degenerate (52) . Patients with neurological sequelae from peripheral neuropathy with spinal cord or brainstem involvements may also be candidates for surface transplantation (53) . We demonstrated that elongated, astrocytic processes after trauma played a crucial role in cell migration (Fig. 4 A-E) , and intriguingly, similar elongated processes in reactive astrocytes are observed in multiple sclerosis (54) . Because we observed neurites from transplanted cells in the cochlear nucleus, surface transplantation may be applied not only to neural systems in the superficial layers of the nervous system but also to those in deeper locations. Such targets could include the substantia nigra and the caudate nucleus, which may be approachable via cisternal and intraventricular routes.
In conclusion, the glial scar has been regarded as a major barrier for cell transplantation therapy, but we show that this is not necessarily the case if donor cells are applied appropriately to the host with minimal tissue damage. Our method of surface transplantation potentially opens the way to more efficient and less invasive approaches for cell transplantation in many forms of CNS and PNS disorders.
Materials and Methods
Glial Scar Induction in Rat Auditory System by Mechanical Compression to Auditory Nerve. Animal experiments were conducted in accordance with the Guidelines for Animal Experiments at Kyoto University. Exposing of the auditory nerve of male Sprague-Dawley rats (P7-8 wk) was performed as previously reported (7, 8, 10, 11) . For compression, a nerve hook (tip diameter: 0.15 mm, No. 10140-03; Fine Science Tools) with the tip bent at a 150°angle was placed onto the auditory nerve at the internal auditory meatus, and the nerve was mechanically injured by a single compression (Fig. S1A) .
Cell Transplantation. To treat the nerve topically with enzyme, we applied a piece of absorbable gelatin sponge (2.0 mm 3 , Spongel; Astellas Pharma) soaked in 20 μL (0.2 U) ChABC (Seikagaku; Sigma-Aldrich), first at the time of nerve injury and second immediately after cell transplantation. Five weeks after auditory nerve mechanical injury, we reopened the operative site and inserted a fused silica tube (external and internal diameter, 105 and 40 μm, respectively; Eicom) into the auditory nerve trunk (Fig. S1B) . For surface transplantation, we placed a fused silica tube ∼500 μm away from the surface of auditory nerve in the cerebellopontine angle cistern (Fig. S1B) . In both experiments, we applied another ChABC-soaked gelatin sponge and covered the site with fibrin glue (Beriplast-P Combi-set, CSL Behring; Bolheal, Kaketsuken). We then infused 17,500 ± 2,400 cells (average ± SD) in 2 μL of high-concentration Matrigel (BD), with basic FGF (Peprotech; 25 ng/mL) that aids cell differentiation (12) , using a microinjector (Micro 4; World Precision Instruments) with an infusion speed of 1,000 nL/min. Valproic acid (Wako) was orally administered in drinking water (480 mg/kg body weight per day) to enhance neurite extension (55) from 1 wk before cell transplantation until the day of perfusion/fixation for 18 wk.
Immunohistochemistry. Temporal bones were obtained and processed as previously reported (7, 8, 10, 11) . The section angle was chosen so that the auditory nerve trunk, PVCN, and DCN were simultaneously included in one section as fully as possible by reference to figures 1 and 2 in Hackney et al. (56) . Primary antibodies used in the current study are listed in SI Materials and Methods and Fig. S1C .
Quantification of Immunofluorescence Intensity. Images were obtained with identical confocal microscope and microscope settings throughout capturing of images; the fluorescence intensities of GFAP in sham and experimental samples were compared at the same threshold (n = 4). In 1G2 and 2B6 antibodies, the fluorescence intensity in sham samples was manually reduced to approximately zero level, and at this level, the images of experimented specimens were photographed (n = 4). Images were converted into grayscale images with Photoshop (CS3; Adobe) and transferred to National Institutes of Health's Image J, and positive pixel area (PPA) was analyzed applying the same threshold.
Western Blotting of GFAP. Samples were collected from experimental rats, 4 wk after compression (right side, n = 19), and those from sham rats were used as control. After processing, proteins were separated on a SuperSep Ace gel (Wako) and transferred onto a PVDF membrane (GE Healthcare). Membranes were probed with GFAP antibody (1:15,000; DAKO; rabbit polyclonal) overnight, and HRP-linked anti-rabbit IgGs (1:10,000; GE Healthcare) were applied as the secondary antibody. GAPDH was used as a loading control. Detailed information is listed in SI Materials and Methods.
qRT-PCR. The samples were collected from the rats 1, 4, and 25 wk after compression (15 rats for each time point). Total RNA was extracted using an RNeasy Mini Kit (Qiagen). Single-stranded cDNA was synthesized with a High Capacity cDNA synthesis kit (Applied Biosystems). Real-time PCR primers and probes were obtained from Applied Biosystems (CSPG3, Neurocan, Rn00581331_m1; GFAP, Rn00566603_m1; Nestin, Rn00564394_m1). The data were acquired in triplicate. Gene expression values, normalized to GAPDH expression, were determined by using the comparative Ct method (ΔΔCt method). Detailed information is listed in SI Materials and Methods.
ELISA Samples collected from 30 rats (5-10 wk after compression) were processed after Elfving et al. (57) . ELISA study was performed with a Promega BDNF Emax ImmunoAssay System following the manufacturer's instructions. Detailed information is listed in SI Materials and Methods.
Counting of Spiral Ganglion Cells, Transplanted Cells, and Cochlear Nucleus Cells. In four sham rats, six rats with ABR improvement, and four rats without ABR improvement, we counted the numbers of spiral ganglion cells with nuclei in Rosenthal's canal in the basal cochlear turn (approximately corresponds to 70-100% of entire cochlear length from the cochlear apex), middle turn (70-30%), and apical turn (−30%) (58) in every fourth section in each rat. In the latter two groups of rats, GFP+ transplanted cells were counted. For quantification of cochlear nucleus cells, we chose a section that included auditory nerve root, PVCN, and DCN most widely among the sections and counted cells with synaptophysin+ endbulbs in sham rats and those with GFP+ synaptophysin+ endbulbs in experimental rats in five randomly selected regions that approximately evenly covered the entire PVCN (each region size, 270 × 270 μm) in each animal (five rats with ABR improvement and four rats without ABR improvement).
ABR Recording. We recorded tone burst ABR three times in each animal before auditory nerve injury, 5 wk after nerve injury before cell transplantation, and 3 mo after cell transplantation as previously reported (59) . White noise (40 dB) was applied to the contralateral ear to prevent the contribution from nontested ear. We measured wave III amplitude as shown in Fig. S2C at 85 dB SPL at 8 and 16 kHz and 75 dB at 4 kHz to avoid large cochlear microphonics at 85 dB in this frequency.
Statistical Analysis. An unpaired or paired Student two-tailed t test was performed using Excel 2013 (Microsoft). For all statistical tests, P < 0.05 was used as the criterion for statistical significance. In all figures, error bars indicate SD.
